Skip to main content
. 2022 Sep;50(9):1302–1311. doi: 10.1124/dmd.122.000877

Fig. 5.

Fig. 5.

S-warfarin metabolic profiles in subjects with different CYP2C9 genotypes after the administration of warfarin alone (A) and warfarin together with fluconazole (B) or rifampin (C). Color represents different elimination pathway as shown in the figure legend.